Company Analysis

WORK Medical Technology Group LTD (WOK)

Nasdaq: WOK · Surgical & Medical Instruments & Apparatus · Hangzhou · filing with the SEC since 2022
Grade3.9
◀ Past 3.4● Present 3.9▶ Future 4.6
1 est.

The grade of WORK Medical Technology Group LTD

Nine metrics read from its own filings, by tense
Headline grade
3.9/10
◀ Past3.430% of the headline
● Present3.940% of the headline
▶ Future4.630% of the headline

All three tenses have at least two readings, so the archetype blend applies as printed.

Of the nine metrics, 8 read as filed from the record and 1 is an SI estimate, each with its reasoning, its confidence and what would change it on its card.

◀ Past

What did they actually do?

3.4/1030% of the headline grade · 3 of 3 filed

Surviving crises

as filed
5.5/10

Has it survived what it has been through?

1 warning event since 2022; the latest 2025-01-31.

weight 33% of this tense · 55th percentile among 121 sector filers · read for itself

From the record

WORK Medical Technology Group LTD's filings since 2022 show 1 warning event: a late-report notice (Form NT 10-K or NT 10-Q, the latest 2025-01-31) (its current reports).

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Track record

as filed
2.4/10

What has it actually done, year after year?

-20.6% a year over 4 filed years; profitable in 2 of 4.

weight 45% of this tense · 24th percentile among 105 sector filers · read for its customers

From the record

WORK Medical Technology Group LTD's 4 filed years say what it did: revenue went from $20 million in fiscal 2022 to $10 million in fiscal 2025, down 20.6% a year; it rose in 0 of 3 years; the deepest fall was 50% from fiscal 2022 to fiscal 2025; net income was positive in 2 of 4 of those years (its annual reports).

What it rests on

  • revenue growth over the filed span-20.6%bottom 6% of its family
  • the share of years revenue rosebottom 2% of its family
  • the share of filed years with a profittop 30% of its family
  • the deepest fall from a revenue peak50.0%bottom 18% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Shareholder treatment

as filed
2.3/10

How has it treated the people who own it?

Share count grew 32.3% a year. 0% of cash flow returned. Insiders: 0 sales, 0 purchases.

weight 22% of this tense · 23rd percentile among 40 sector filers · read for its shareholders

From the record

Over the 3 fiscal years to 2025-09-30, WORK Medical Technology Group LTD's diluted share count grew about 32.3% a year, and dividends and buybacks returned about 0% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 0 sales and 0 purchases of their own stock on the open market in the year to 2026-09-30 (their Form 4 filings).

What it rests on

  • the share count over the yearsbottom 32% of its family
  • cash returned against operating cash flowbottom 13% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

● Present

What are they doing right now?

3.9/1040% of the headline grade · 2 of 3 filed, 1 estimated

Financial health

as filed
4.0/10

Is it financially healthy right now?

ROE -5%: lost 5¢ per shareholder dollar. Leverage 36%: owes 36¢ per asset dollar.

weight 45% of this tense · 40th percentile among 120 sector filers · read for itself

From the record

Return on equity: in the fiscal year ended 2025-09-30, WORK Medical Technology Group LTD lost about 5 cents for every dollar of shareholders' money, and gross profitability: its products earned about 7 cents per dollar of everything the company owns. Leverage: it owed about 36 cents per dollar of assets, and net share issuance: its share count grew 128.1% over the year (the filed statements).

What it rests on

  • what it owes per dollar of assetstop 41% of its family
  • return on equitytop 31% of its family
  • gross profit against assetsbottom 16% of its family
  • the share count against the year beforebottom 18% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Industry position

as filed
3.0/10

How strong is its position in its industry?

bottom 30% of 109 in its family; net margin -10.9%.

weight 33% of this tense · 30th percentile among 109 sector filers · read for its customers

From the record

WORK Medical Technology Group LTD's standing among 109 graded names in its industry family: revenue of $10 million in fiscal 2025 ranks in the bottom 23% by size; a net margin of -10.9% ranks in the top 41%; revenue growth of -20.6% a year over the last 3 filed years ranks in the bottom 7% (its annual reports).

What it rests on

  • revenue against the family$9.8Mbottom 23% of its family
  • net margin-10.9%top 41% of its family
  • three-year revenue growth-20.6%bottom 7% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Leadership

SI estimate
5.0/10

What are the people in charge doing?

SI estimate 5.0/10, confidence 20 of 100 (family median).

weight 22% of this tense · 50th percentile among 105 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate
It files no Form 8-K (a foreign issuer reports on Form 6-K), so officer and director changes cannot be read there; the record of its people begins on 2026-05-28 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 6 months and cannot see past it; a floor under five years is not read as years in charge, so the desk assumes the typical reading of its industry family, the median of 105 members with one.
What the record cannot read
It files no Form 8-K (a foreign issuer reports on Form 6-K), so officer and director changes cannot be read there; the record of its people begins on 2026-05-28 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 6 months and cannot see past it; a floor under five years is not read as years in charge.
How it was reasoned
family median, 105 readings behind it.
Confidence
20 of 100
What would change it
Its next annual report on file with the inputs replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: WORK Medical Technology Group LTD's leadership is put at 5.0 of 10 with a confidence of 20 of 100, because it files no Form 8-K (a foreign issuer reports on Form 6-K), so officer and director changes cannot be read there; the record of its people begins on 2026-05-28 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 6 months and cannot see past it; a floor under five years is not read as years in charge, so the desk assumes the typical reading of its industry family, the median of 105 members with one. Its next annual report on file with the inputs replaces this estimate with the filed reading.

▶ Future

What are they set up to do next?

4.6/1030% of the headline grade · 3 of 3 filed

Room to expand

as filed
4.5/10

How much room does it have to grow?

bottom 45% of 104 in its family for room to expand.

weight 45% of this tense · 45th percentile among 104 sector filers · read for itself

From the record

WORK Medical Technology Group LTD's room to grow, from the newest filed statements (fiscal 2025): cash of $4 million against no long-term debt tagged leaves 12.3% of its assets as net cash, top 47% of its family; cash from operations less capital spending is 49.9% of revenue (top 1%); a gross margin of 23.8% (bottom 8%); research spending of 4.4% of revenue (bottom 21%) (its annual report).

What it rests on

  • cash less debt against assets12.3%top 47% of its family
  • cash from operations less capital spending against revenue49.9%top 1% of its family
  • gross margin23.8%bottom 8% of its family
  • research spending against revenue4.4%bottom 21% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Growth drivers

as filed
4.7/10

What could actually drive growth from here?

bottom 47% of 105 in its family for growth drivers.

weight 33% of this tense · 47th percentile among 105 sector filers · read for its customers

From the record

WORK Medical Technology Group LTD's growth drivers, from the filed years to fiscal 2025: revenue grew -20.6% a year over the last three filed years against -20.6% over all 4, speeding up (top 43% of its family); the newest year grew -14.4% (bottom 11%); research spending grew 33.3% a year (top 13%); capital spending grew -12.8% a year (bottom 35%) (its annual reports). WORK Medical Technology Group LTD tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

What it rests on

  • three-year growth against the whole span+0.0 points a yeartop 43% of its family
  • the newest year's revenue growth-14.4%bottom 11% of its family
  • three-year growth of research spending33.3%top 13% of its family
  • three-year growth of capital spending-12.8%bottom 35% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Expectations vs reality

as filed
4.3/10

Did its newest year beat what its own record pointed to?

bottom 43% of 88 in its family for expectations against reality.

weight 22% of this tense · 43rd percentile among 88 sector filers · read for its shareholders

From the record

WORK Medical Technology Group LTD's newest year against its own record: revenue of $10 million in fiscal 2025 came in 12% above the $9 million its prior three years' pace pointed to (top 14% of its family); net income of $1 million against a prior three-year average of $838 thousand (bottom 23%); a net margin of -10.9% against -8.4% before (bottom 21%) (its annual reports).

What it rests on

  • revenue against the prior three years' pace12.0%top 14% of its family
  • net income against the prior three years' average-28%bottom 23% of its family
  • net margin against its prior average-2.5 pointsbottom 21% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made

SI Assistanton WOK · research, not advice